meretricious 发表于 2025-3-23 12:52:30

http://reply.papertrans.cn/1/5/438/438-11.png

水獭 发表于 2025-3-23 17:11:57

Submitted on: 28 October 2024.
Revised on: 07 February 2025.
Accepted on: 06 March 2025.

___________________Acta Pharmaceutica Sinica B---INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES

Aspirin 发表于 2025-3-23 19:25:35

Submitted on: 11 September 2013.
Revised on: 28 November 2013.
Accepted on: 23 January 2014.

___________________Acta Pharmaceutica Sinica B---INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES

Terrace 发表于 2025-3-23 23:37:37

Submitted on: 21 February 2018.
Revised on: 27 May 2018.
Accepted on: 21 June 2018.

___________________Acta Pharmaceutica Sinica B---INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES

GRIN 发表于 2025-3-24 04:43:46

Submitted on: 24 May 2009.
Revised on: 10 September 2009.
Accepted on: 19 October 2009.

___________________Acta Pharmaceutica Sinica B---INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES

Jubilation 发表于 2025-3-24 06:48:59

http://reply.papertrans.cn/1/5/438/438-16.png

brassy 发表于 2025-3-24 12:32:08

http://reply.papertrans.cn/1/5/438/438-17.png

insincerity 发表于 2025-3-24 16:42:52

http://reply.papertrans.cn/1/5/438/438-18.png

否决 发表于 2025-3-24 20:12:45

Submitted on: 27 April 2022.
Revised on: 21 August 2022.
Accepted on: 05 September 2022.

___________________Acta Pharmaceutica Sinica B---INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES

管理员 发表于 2025-3-25 00:03:30

http://reply.papertrans.cn/1/5/438/438-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊Acta Pharmaceutica Sinica B 2024/2025影响因子:14.748 (ACTA PHARM SIN B) (2211-3835). (PHARMACOLOGY & PHARMACY)(药理学与药学